StonvexLoading…
StonvexStonvexStonvexCore line items from SDGR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $255.87M | $207.54M | $216.67M | $180.96M |
Operating Income | $-166.90M | $-209.30M | $-177.45M | $-146.82M |
Net Income | $-103.27M | $-187.12M | $40.72M | $-149.19M |
EPS (Diluted) | $-1.41 | $-2.57 | $0.54 | $-2.10 |
Total Assets | $726.16M | $823.23M | $802.96M | $688.59M |
Total Liabilities | $362.11M | $401.78M | $254.40M | $240.68M |
Cash & Equivalents | $230.52M | $147.33M | $155.31M | $90.47M |
Free Cash Flow OCF − CapEx | $12.46M | $-164.68M | $-150.14M | $-127.70M |
Shares Outstanding | 73.44M | 72.67M | 62.98M | 62.16M |